
Ming Wang
Articles
-
Jan 19, 2025 |
nature.com | Zhe Huang |Ming Wang |Tao Li |Jie Zhou
AbstractAlmost all high-grade gliomas, particularly glioblastoma (GBM), are highly migratory and aggressive. Migrasomes are organelles produced by highly migratory cells capable of mediating intercellular communication. Thus, GBM cells may produce migrasomes during migration. However, it remains unclear whether migrasomes can influence GBM migration and invasion. In this study, we observed the presence and formation of migrasomes in GBM cells.
-
Nov 27, 2024 |
pubs.acs.org | Mengyang Li |Zheng Li |Ming Wang |Zheng Tang
-
Nov 22, 2024 |
mdpi.com | Ming Wang
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
-
Nov 19, 2024 |
mdpi.com | Menglu Liang |Zheng Li |Lijun Zhang |Ming Wang
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
-
Aug 22, 2024 |
nature.com | Hamlet Gasoyan |Faiz Anwer |Nicholas J. Casacchia |Ming Wang |Michael Halpern
AbstractThis retrospective cohort study used Taussig Cancer Center’s Myeloma Patient Registry to identify adults with multiple myeloma diagnosed between January 2017-December 2021. Electronic health records data captured time from diagnosis to initial prescription fill for oral antimyeloma medications and initiation of facility administered or oral antimyeloma treatment.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →